AstraZeneca (NYSE: AZN) announced that the FDA has approved Bydureon (exenatide extended-release) for injectable suspension as an add-on therapy to basal insulin in adults with type 2 diabetes with ...

Below are 3 natural substitutes to Bydureon that can reduce body weight and control blood sugar levels. For best results it is possible to use in a stack – this means combining 2 or more products ...

Indonesia will increase imports of U.S. food and commodities and reduce orders from countries the Southeast Asian nation currently buys the products from, chief economic minister Airlangga Hartarto ...

Alert US Is First Market for Bydureon Pen for Type 2 Diabetes A new product contains the same formulation and dosing of current extended-release exenatide but eliminates the need for filling a syringe ...

SAN DIEGO, June 24 (Reuters) - Analysis of an earlier trial found a "clinically insignificant" link between changes in heart rhythms and use of Bydureon, a long-acting diabetes drug being developed by ...

Exenatide ext-rel 2mg; susp for SC inj; contains sucrose. <10yrs: not established. Give by SC inj in abdomen, thigh, or upper arm; rotate inj sites. Inject immediately after mixing. ≥10yrs: 2mg once ...